Melanie Schürz
PhDMelanie Schürz is a biomedical researcher with a focus on imaging-based method development. She leads our research program Nanovesicular Therapeutics.
Melanie has a background in genetics and biology and during her PhD, she worked on oxidative stress in the liver with a focus on HNE-modified proteins and lipofuscin. Alongside she assessed environmental toxicity in Kosovo using cell biological assays. She joined the NMK lab in 2019 as a postdoctoral researcher within the EVTT (Extracellular Vesicle Theralytic Technologies) Centre, where she contributed her expertise in complex cellular models and developed imaging-based technologies for high-content characterization and tracking of nanovesicles at the single-vesicle, single-cell and whole-organ level. Together with software engineer Joachim Danmayr, she developed EVAnalyzer, an open-source tool for the automated quantification of EVs from imaging data, which since evolved, together with a growing application repertoire, into a comprehensive standalone software (Enhanced visual analyzer 2). During those years she additionally worked on generation of antiviral extracellular vesicles for decoy and competition against different variants of concern of the SARS-CoV-2 virus, on passive EV loading with hydrophobic and cholesterol- tagged small molecules, on systematic evaluation of numerous different EV labelling strategies and on EV, LNP fusions.
After transitioning into a group leader role in 2025 she now leads our Research Group for Nanovesicular Technologies, where she and her team continues the development of a comprehensive catalogue of theralytic methodologies for nanovesicle characterisation and EV tracking in vitro and in vivo.
My Superpower: Finding and tracing fluorescent spots across in vitro and in vivo settings
Me as a vesicle: I do not only travel (through the microscope into a small new world), but I deliver: turning raw signal into meaningful biological data.